1. Home
  2. AWRE vs INKT Comparison

AWRE vs INKT Comparison

Compare AWRE & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

N/A

Current Price

$2.13

Market Cap

44.7M

Sector

Technology

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$11.79

Market Cap

51.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AWRE
INKT
Founded
1986
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
51.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AWRE
INKT
Price
$2.13
$11.79
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
28.2K
21.3K
Earning Date
10-29-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.72
N/A
52 Week Low
$1.37
$4.56
52 Week High
$2.95
$76.00

Technical Indicators

Market Signals
Indicator
AWRE
INKT
Relative Strength Index (RSI) 45.19 45.91
Support Level $2.07 $11.55
Resistance Level $2.22 $12.68
Average True Range (ATR) 0.12 0.87
MACD 0.00 0.14
Stochastic Oscillator 40.03 44.52

Price Performance

Historical Comparison
AWRE
INKT

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: